Investment Summary |
|
|---|---|
| Date | 2010-02-16 |
| Target | Radpharm Scientific Pty. |
| Sector | Medical Products |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Merger |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 51 |
| Sector (Medical Products) | 4 of 13 |
| Type (Merger) | 1 of 2 |
| State (New Jersey) | 1 of 5 |
| Country (United States) | 12 of 49 |
| Year (2010) | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-02-05 |
Medifacts International
Rockville, Maryland, United States Medifacts International, Inc. is a provider of cardiac safety services for biopharmaceutical and medical device sponsors. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-15 |
Signature Genomic Laboratories
Spokane, Washington, United States Signature Genomic Laboratories, LLC is a provider of microarray-based cytogenetic diagnostics with its proprietary SignatureChip and is the major in providing microarray-based chromosome analysis. |
Sell | - |
